Related Experiment Videos
Restenosis: Relationship with Thrombosis
1Cardiology Division, Department of Internal Medicine, University of Texas Health Sciences Center, 6431 Fannin, Room MSB-246, Houston, TX 77025-0708, USA. Smalling@heart.med.uth.tmc.edu
Current Interventional Cardiology Reports
|November 30, 2000
Summary
Coronary restenosis after angioplasty remains a challenge. This review explores the role of the hemostatic system in restenosis and potential therapies to inhibit it.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Hemostasis Research
Background:
- Percutaneous coronary intervention (PCI) has evolved significantly since 1977.
- Despite advances, chronic restenosis of dilated coronary lesions persists as a major clinical issue.
- Restenosis involves vessel recoil, remodeling, hemostatic activation, thrombosis, and neointimal hyperplasia.
Purpose of the Study:
- To review the mechanisms of coronary restenosis.
- To investigate the role of the hemostatic system in the restenotic process.
- To discuss potential therapeutic strategies targeting the hemostatic system to prevent restenosis.
Main Methods:
- Literature review of studies on coronary angioplasty and restenosis.
- Analysis of the pathophysiology of neointimal hyperplasia and thrombosis.
- Evaluation of existing and potential anti-hemostatic therapies for restenosis.
Main Results:
- Coronary stenting mitigates vessel recoil and remodeling but not restenosis.
- Thrombosis at the injury site is a key factor in neointimal hyperplasia and restenosis, particularly in animal models.
- The hemostatic system plays a significant role in the development of restenosis.
Conclusions:
- No definitive therapy currently prevents restenosis after PCI.
- Targeting the hemostatic system presents a promising avenue for preventing chronic restenosis.
- Further research into anti-hemostatic drugs and techniques is warranted to combat restenosis.